Target intelligence / Profile preview

Fetus

01

Overview

A fetus is the prenatal stage of a viviparous mammal between the embryonic stage and birth; in humans, this begins at the ninth week of gestation. In pharmacology, the fetus is not classified as a molecular target but is considered a highly sensitive patient population and a site for potential drug-induced toxicity or therapeutic intervention. Drugs reaching the fetus must typically cross the placental barrier, where they may interact with fetal-specific isoforms of enzymes or receptors. Understanding the physiological and developmental state of the fetus is essential for evaluating the safety profiles of maternal medications and for the field of fetal therapy, which aims to treat conditions like congenital diaphragmatic hernia or cardiac arrhythmias in utero.

Other names
Unborn offspringDeveloping embryo (post-organogenesis)
02

Mechanism of action

The fetus is a multicellular organism rather than a molecular target. Drugs interact with specific receptors, enzymes, or signaling pathways within fetal tissues or the placenta to exert therapeutic or toxic effects (e.g., corticosteroids inducing surfactant production via glucocorticoid receptors).

03

Biological functions

OrganogenesisGrowth and developmentHematopoiesisThermoregulation (in utero)Metabolic maturation
04

Disease associations

Fetal growth restrictionCongenital anomaliesChromosomal abnormalitiesFetal hydropsIntrauterine infection
05

Safety considerations

TeratogenicityDevelopmental toxicityPlacental transfer of drugsNeonatal withdrawal syndromeEndocrine disruption
06

Interacting drugs

Betamethasone

5 more in the full profile.

07

Biomarkers

Alpha-fetoprotein (AFP)Cell-free fetal DNA (cffDNA)Pregnancy-associated plasma protein A (PAPP-A)Human chorionic gonadotropin (hCG)

Beyond the preview

Go deeper on Fetus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fetus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call